If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMCM.L Regulatory News (MCM)

  • There is currently no data for MCM

Form 8.3 - Motivcom PLC

18 Sep 2014 10:23

RNS Number : 0171S
Slater Investments Ltd
18 September 2014
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

Slater Investments Ltd

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Motivcom Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

11/09/2014

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,520,000

5.59%

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

1,520,000

5.59%

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

18/09/2014

Contact name:

Klaudia Domanska/Sian Simpson

Telephone number:

02072209460

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETUWUKRSUAKARR
Date   Source Headline
24th Jan 20249:30 amRNSNon-Binding and Indicative Proposal Update
22nd Dec 20238:32 amRNSNon-Binding and Indicative Proposal Update
22nd Dec 20237:30 amRNSOperations & Trading Update
18th Dec 20233:30 pmRNSDirector/PDMR Shareholding
18th Dec 20233:02 pmRNSREVISED NON-BINDING AND INDICATIVE PROPOSAL
30th Nov 20232:31 pmRNSResult of Annual General Meeting
27th Nov 20233:03 pmRNSAnnual General Meeting Details
8th Nov 20237:15 amRNSIssue of Equity
2nd Nov 20231:15 pmRNSReceipt of Notice of Intention to Make a Takeover
31st Oct 20232:30 pmRNSDespatch of Annual Report and Notice of AGM
31st Oct 20239:25 amRNSActivities Report for the Quarter Ended 30 Sep 23
31st Oct 20239:25 amRNSAppendix 5B
27th Oct 202310:30 amRNSIssue of Equity
5th Oct 202310:30 amRNSAnnual General Meeting Details
21st Sep 202312:13 pmRNSResults for the Full Year Ended 30 June 2023
15th Sep 202310:10 amRNSChange of Australian Share Registry Address
31st Jul 20239:35 amRNSAppendix 5B
31st Jul 20239:33 amRNSACTIVITIES REPORT FOR QUARTER ENDED 30 JUNE 2023
25th Jul 20237:45 amRNSIDC Extension Announcement
30th Jun 202312:15 pmRNSTrading Update
28th Apr 20239:35 amRNSAppendix 5B
28th Apr 20239:30 amRNSActivities Report for the Quarter Ended 31 Mar 23
27th Apr 20239:00 amRNSHolding(s) in Company
26th Apr 202311:20 amRNSMakhado Project Update
31st Mar 20238:02 amRNSIssue of Shares Under the Performance Rights Plan
16th Mar 20237:00 amRNSChange of JSE Sponsor
15th Mar 20237:40 amRNSInterim Financial Report
15th Mar 20237:40 amRNSHalf-year Results
10th Mar 20231:00 pmRNSDirector Appointments & Resignation
22nd Feb 20232:05 pmRNSSecond Price Monitoring Extn
22nd Feb 20232:00 pmRNSPrice Monitoring Extension
31st Jan 20237:31 amRNSAppendix 5B
31st Jan 20237:30 amRNSActivities Report for the Quarter Ended 31 Dec 22
19th Jan 20232:15 pmRNSGrant of Options & Performance Rights to Directors
23rd Dec 20228:37 amRNSOutsourcing of the Vele Aluwani Colliery
20th Dec 20223:00 pmRNSExtension of Coal Sales & Marketing Agreement
1st Dec 20229:00 amRNSIDC Loan Update
30th Nov 20224:32 pmRNSResult of AGM
11th Nov 20226:20 pmRNSDirectors' Dealings
4th Nov 20222:06 pmRNSSecond Price Monitoring Extn
4th Nov 20222:00 pmRNSPrice Monitoring Extension
4th Nov 202210:00 amRNSFully Underwritten Rights Issue Offer Closes
31st Oct 20229:31 amRNSAppendix 5B
31st Oct 20229:30 amRNSActivities Report for the Quarter Ended 30 Sep 22
31st Oct 20227:00 amRNSDespatch of Annual Report and Notice of AGM
7th Oct 202211:07 amRNSAnnual General Meeting Details
30th Sep 20229:45 amRNSResults for the Full Year Ended 30 June 2022
28th Sep 20222:05 pmRNSSecond Price Monitoring Extn
28th Sep 20222:00 pmRNSPrice Monitoring Extension
27th Sep 20227:00 amRNSFully Underwritten A$40M Rights Issue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.